Published in Health Business Week, October 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at BioProgress.
Report 1: The Board of BioProgress (AIM: BPRG), the specialty pharmaceutical and healthcare company has noted the recent fall in its share price and whilst recognising the volatility in the UK stock market generally, provides the following update.
Following the announcement on 28 June 2007 of the acquisition of Melbrosin, BioProgress is pleased to announce that the integration of the new business is progressing well. The core products are performing to plan and cross...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.